STATISTICAL DESIGN AND DEVELOPMENT OF A LIQUID ORAL FLOATING IN SITU GEL OF METFORMIN HYDROCHLORIDE FOR SUSTAINED RELEASE: PHARMACODYNAMIC AND TOXICITY (HISTOPATHOLOGY) STUDIES

  • RASHMI MATHEWS Department of Pharmaceutics
  • B. PRAKASH RAO Department of Pharmaceutical Technology
  • ABBULU KONDE CMR College of Pharmacy, Affiliated to JNTUH, Hyderabad, India 501512
  • SUDARSHAN S. Department of Pharmaceutics
  • NAWRES A. TAHA Department of Pharmacology, Karnataka College of Pharmacy, #33/2, Thirumenahalli, Hegde Nagar Main Road, Jakkur PO, Bangalore, India 560064
  • SURESH C. Department of Pharmaceutics

Abstract

Objective: To statistically design, optimize and evaluate a liquid oral, floating in situ gel of Metformin hydrochloride (MH) to increase the gastric residence time (the absorption window being upper part of the duodenum), sustain and modulate the release behavior of the drug, as no liquid oral SR formulations of MH are yet available in the market.


Methods: A simple mixing based ionic cross-linking method was used for the formulation.  A Two-square Factorial Design was employed and effect of sodium alginate and three categorical levels of HPMC (K4M, K100M, E50) on the response variables studied.


Results: The optimized formulation gelled instantaneously in simulated gastric fluid, showed > 24 h floating. The drug release in 1h was 37.98 %, followed by moderate sustained release for 12 h.  Pharmacodynamic studies showed significant reduction in blood glucose levels in Wistar rats. Short term preclinical safety studies revealed no toxicity to pancreatic tissues. On the contrary, faster regeneration of the β cells of the islets of Langerhans was observed with the group treated with the optimized formulation. Stability studies revealed a 2-year shelf life


Conclusion: An elegant, needle-free, in situ gelling, SR liquid oral of Metformin Hydrochloride could be developed with drug release modulated as per official specifications for SR formulations of MH. This is an interesting alternative for geriatric patients who find it difficult to swallow bulky tablets

Keywords: Liquid Oral floating in situ gel, Metformin Hydrochloride, Least square Fit model, Pharmacodynamic study, toxicity studies

References

1. Xu H, Shi M, Liu Y, Jiang J, Ma TA. Novel in situ gel formulation of ranitidine for oral sustained delivery. Biomol Ther 2014;22:161-5.
2. Zhidong L, Jaiwei L, Shufang N, Hui L, Pingtian D, Weisan P. Study of an pharm alginate-HPMC based in situ gelling ophthalmic delivery system for gatifloxacin. Int J 2006;315:12-7.
3. Uchida T, Yastake T, Goto S. Utility of mixture of commercially available polymer as constituents of sustained release microcapsules. Chem Pharm Bull 1992;40:463-6.
4. Ravi Kumar MNV. Nano and microparticle as controlled drug delivery devices. J Pharm Sci 2000;3:234-58.
5. Rao GU, Pawan M. Buoyant sustained release drug delivery systems current potentials advancements and role of polymers: a review. Int J Clin Pharm 2012;2:1-7.
6. Rabadia N, Tiwari A, Patel G, Virani V. The floating drug delivery system and its impact on calcium channel blocker: a review article. Int J Pharm Res Dev 2011;3:107-31.
7. Sarasija S, Shyamala B. Nasal drug delivery: an overview. Indian J Pharm Sci 2005;67:19-25.
8. Jadhav SL, Banerjee SK. Formulation and evaluation of floating in situ gel of nizatidine. Int J Res Pharm Sci 2013;4:250-5.
9. Qiu Y, Park K. Environment-sensitive hydrogels for drug delivery. Adv Drug Delivery Rev 2001;53:321-39.
10. Concheiro A. Crosslinked ionic polysaccharides for stimuli sensitive drug delivery. Adv Drug Delivery Rev 2013;65:1148-71.
11. Wataru K, Yasuhiro K, Miyazaki S, Attwood D. In situ gelling pectin formulations for oral sustained delivery of paracetamol. Drug Dev Indian Pharm 2004;30:593-9.
12. Bhalerao KK, Kamble MS, Aute PP, Dange SM, Chavan RP, Vaidya KK, et al. A short review on a stomach specific floating in situ gel. J Biomed Pharm Res 2012;1:1-4.
13. Prajapati VD, Jani GK, Zala BS, Khutliwala TA. An insight into the emerging exopolysaccharide gellan gum as a novel polymer. Carbohydrate Polymers 2013;93:670-8.
14. Armin M. Stability and release kinetics of an advanced gliclazide-cholic acid formulation: the use of artificial-cell microencapsulation in slow release targeted oral delivery of antidiabetics. J Pharm Int 2014;9:150-7.
15. Artiga AM, Acevedo FA, Martin BO. Effect of sodium alginate incorporation procedure on the physicochemical properties of nanoemulsions. Food Hydrocolloids 2017;70:191-200.
16. Narayani R, Bagavad Gita V, Amarnathan T. Preparation and evaluation of alginate films for periodontal drug delivery. Trends Bio Mater Artif Organs 2000;14:1-4.
17. Tapan AM, Villafuerte RL. Effect of formulation and process variables on the release behavior of amoxicillin matrix tablets. Drug Dev Indian Pharm 2004;30:901-8.
18. Jaipal A, Pandey MM, Charde SY, Raut PP, Prasanth KV, Prasad RG. Effect of HPMC and mannitol on drug release and bio adhesion behavior on buccal discs of buspirone hydrochloride: in vitro and in vivo pharmacokinetic studies. Saudi Pharm J 2015;23:315-26.
19. Ching MO, Paul WSH, Lai WC. A study on the impact of hydroxypropyl methylcellulose on the viscosity of PEG melt suspensions using surface plots and principal component analysis. AAPS PharmSciTech 2015;16:466-77.
20. Miyazaki S. The effect of taste masking agents on in situ gelling pectin formulations for oral sustained delivery of paracetamol and ambroxol. Int J Pharm 2005;297:38–49.
21. Abraham S, Naufal M, Peter V. Formulation and evaluation of gastro-retentive drug delivery system containing combination of glipizide and metformin hydrochloride. Asian J Pharm Clin Res 2016;9:236-40.
22. Kim D, Park J. Development and pharmaceutical approach for sustained release metformin succinate tablets. J Drug Del Sci Tech 2015;30:90-9.
23. Kavin G, Joshi P, Shah M, Ramkishan A, Patel J. Formulation and evaluation of periodontal in-situ gel. Int J Pharm Investig 2013;3:29-41.
24. Chunming Su, Donald LS. In situ infrared speciation of adsorbed carbonate on aluminium and iron oxides. Clay Miner Soc 1997;45:814-25.
25. Shashank NN, Bharani SS, Thakur RS. Formulation and evaluation of pH triggered in situ ophthalmic gel of moxifloxacin HCl. Int J Pharm Sci 2012;4:452-9.
26. Nagarwal RC, Srinatha A, Pandit JK. In situ forming formulation: development, evaluation, and optimization using 33 factorial design. AAPS PharmSciTech 2009;10:977-84.
27. Kubo W, Miyazaki S, Attwood D. Oral sustained delivery of paracetamol from in situ gelling gellan and sodium alginate formulations. Int J Pharm 2003;258:55–64.
28. Nassour L, Hasan I, El-Hammadi M, Abboud H. Floating in-situ-gelling gellan formulations of metformin hydrochloride. J Chem Pharm Res 2014;6:1509-17.
29. Swamy NG, Abbas Z. Mucoadhesive in-situ gels as nasal drug delivery systems: an overview. Asian J Pharm Sci 2013;7:168-80.
30. Mohanambal E, Arun K. Formulation and evaluation of pH-triggered in-situ gelling system of levofloxacin. Int J Pharm Educ Res 2011;45:59, 60.
31. Panwar P, Chourasiya D, Jain G, Sheorey RV. Formulation and evaluation of oral floatable in-situ gel of diltiazem hydrochloride. Int J Novel Drug Del Tech 2012;2:264-70.
32. Rajinikan PS, Balasubramaniam J, Mishra B. Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of helicobacter pylori. Int J Pharm 2007;335:114-22.
33. Thomas LM. Formulation and evaluation of floating oral in-situ gel of metronidazole. Int J Pharm Sci 2014;6:265-9.
34. Miyazaki S. In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride. Int J Pharm 2001;229:29-36.
35. Geethalakshmi A, Roopa K, Poornima S, Sajal KJ, Venkatesh DP. Temperature triggered in situ gelling systems for betaxolol in glaucoma. J Appl Pharm Sci 2013;3:153-9.
36. Patel DM, Patel DK, Patel CN. Formulation and evaluation of floating oral in situ gelling system of amoxicillin. Int Scholarly Res Net 2011;8:1-8.
37. Moin K. Sodium alginate based insitu gelling system of famotidine: preparation and in vivo characterizations. e-JST 2010;5:27-42.
38. Preetha PJ, Karthika K, Rekha NR, Elshafie K. Formulation and evaluation of in situ ophthalmic gel of diclofenac sodium. J Chem Pharm Res 2010;2:528-35.
39. Miyazaki S, Endo K, Kawasaki N, Kubo W, Watanabe H, Attwood D. Oral sustained delivery of paracetamol from in situ gelling xyloglucan formulations. Drug Dev Indian Pharm 2013;29:113-9.
40. Higuchi T. Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963;52:1145-9.
41. Korsmeyer RW, Gurny R, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 1983;15:25-35.
42. Peppas NA. Analysis of fickian and non-fickian drug release from polymers. Pharm Acta Helv 1985;60:110-1.
43. Ahmed TA, Badr Eldina SM, Ahmed OAA, Aldawsari H. Intranasal optimized solid lipid nanoparticles loaded in situ gel for enhancing trans-mucosal delivery of simvastatin. J Drug Delivery Sci Technol 2018;48:499-508.
44. Swathi G, Lakshmi PK. Design and optimizations of hydrodynamically balanced oral in situ gel of glipizide. J Appl Pharm Sci 2015;5:31-8.
45. Deeds MC, Anderson JM, Armstrong AS. Single dose streptozotocin induced diabetes: considerations for study design in islet transplantation models. Lab Anim 2011;45:131–40.
46. Stepensky D, Friedman M, Srour W, Raz I, Hoffman A. Preclinical evaluation of pharmacokinetic-pharmacodynamic rationale for oral CR metformin formulation. J Control Release 2001;71:107-15.
47. Nurdiana S. Changes in pancreatic histology, insulin secretion and oxidative status in diabetic rats following treatment with ficus deltoidea and vitexin. BMC Complement Altern Med 2017;17:290.
48. Madan JR, Adokar BR, Dua K. Development and evaluation of in situ gel of pregabalin. Int J Pharm Investig 2015;56:227-33.
49. Wamorkar V, Varma MM, Manjunath SY. Formulation and evaluation of stomach-specific in-situ gel of metoclopramide using natural, bio-degradable polymer. Int J Res Pharm Biomed Sci 2011;2:193-97.
50. Sarrof R, Shaikh A, Pawar Y, Kumbhar S. Sodium alginate based oral in situ floating gel of metformin hydrochloride. Res J Pharm Bio Chem Sci 2012;3:890-7.
51. Nalawade VV, Peepliwal AL, Shidaye SS, Mhadgut A, Pandey S. Formulation and evaluation of oral sustained release dry suspension of metformin hydrochloride. Eur J Pharm Med Res 2016;3:447-57.
52. Ghica MV, Hirjau M, Lupulease D, Pirvu CD. Flow and thixotropic parameters for rheological characterization of hydrogels. Molecules 2016;21:786.
53. Sara B. Development of an injectable slow release Metformin formulation and evaluation of its potential antitumor effects. Sci Rep 2018;8:3929.
54. Wajchenberg BL. ?-cell failure in Diabetes and preservation by clinical treatment. Endocr Rev 2007;28:187-218.
55. Walvekar MV, Potphode ND, Desai SS, Deshmukh VM. Histological studies of langerhans of pancreas in diabetic mice after curcumin administration. Int J Pharm Clin Res 2016;8:1314-8.
Statistics
46 Views | Downloads
How to Cite
MATHEWS, R., RAO, B. P., KONDE, A., S., S., TAHA, N. A., & C., S. (2019). STATISTICAL DESIGN AND DEVELOPMENT OF A LIQUID ORAL FLOATING IN SITU GEL OF METFORMIN HYDROCHLORIDE FOR SUSTAINED RELEASE: PHARMACODYNAMIC AND TOXICITY (HISTOPATHOLOGY) STUDIES. International Journal of Applied Pharmaceutics, 11(5). Retrieved from https://innovareacademics.in/journals/index.php/ijap/article/view/30793
Section
Original Article(s)